Table 4 Incidence Rate Ratio for ICHa risk factors in the CCPb population
Age | Incidence 10,000 person-years | Incidence Rate Ratio (exposed vs unexposed) |
|---|---|---|
≥ 80 years | 101 (85–120) | 1.5 (0.9–2.2) |
< 80 years | 69 (46–100) | |
Cardiovascular risk factors | ||
Arterial hypertension | ||
Yes | 99 (83–117) | 1.6 (1.1–2.5) |
No | 61 (40–89) | |
Diabetes | ||
Yes | 384 (292–497) | 0.7 (0.6–1.1) |
No | 99 (81–120) | |
Hypercholesterolemia | ||
Yes | 104 (83–128) | 1.4 (0.9–1.8) |
No | 77 (60–97) | |
Comorbidities | ||
Cardiovascular disease* | ||
Yes | 112 (86–145) | 1.4 (1.0–1.9) |
No | 80 (65–97) | |
Ischaemic cardiopathy | ||
Yes | 98 (67–138) | 1.2 (0.8–1.8) |
No | 86 (72–103) | |
Peripheral arterial disease | ||
Yes | 111 (65–178) | 1.3 (0.7–2.1) |
No | 88 (74–103) | |
Ischaemic stroke | ||
Yes | 116 (67–189) | 1.3 (0.8–2.2) |
No | 88 (74–103) | |
Heart Failure | ||
Yes | 72 (50–100) | 0.7 (0.5–1.1) |
No | 96 (80–114) | |
Falls (background) | ||
Yes | 83 (51–126) | 0.9 (0.6–1.4) |
No | 91 (76–107) | |
HAS-BLED score | ||
≥ 3 | 104 (88–122) | 3.3 (1.8–6.1) |
< 3 | 31 (16–56) | |
Medication | ||
NOACc | ||
Yes | 57 (12–165) | 0.4 (0.1–1.4) |
No | 130 (110–151) | |
VKAd | ||
Yes | 103 (77–134) | 1.2 (0.9–1.7) |
No | 84 (69–102) | |
Antiplatelet drugs | ||
Yes | 107 (88–130) | 1.5 (1.1–2.1) |
No | 69 (53–90) | |
Statins | ||
Yes | 85 (68–105) | 0.9 (0.6–1.2) |
No | 96 (75–120) | |